SEGUELLA, LUISA
 Distribuzione geografica
Continente #
NA - Nord America 1.189
EU - Europa 646
AS - Asia 297
AF - Africa 68
OC - Oceania 7
SA - Sud America 2
Totale 2.209
Nazione #
US - Stati Uniti d'America 1.171
IT - Italia 457
SG - Singapore 177
IN - India 77
TG - Togo 37
FR - Francia 36
CN - Cina 32
AT - Austria 31
BG - Bulgaria 28
NG - Nigeria 26
SE - Svezia 17
CA - Canada 16
DE - Germania 11
FI - Finlandia 11
GB - Regno Unito 11
IE - Irlanda 8
AU - Australia 7
ES - Italia 6
BE - Belgio 5
UA - Ucraina 5
NL - Olanda 4
PL - Polonia 4
EG - Egitto 3
GR - Grecia 3
JP - Giappone 3
RO - Romania 3
CH - Svizzera 2
GT - Guatemala 2
HR - Croazia 2
IQ - Iraq 2
MV - Maldive 2
MY - Malesia 2
ZA - Sudafrica 2
AR - Argentina 1
CL - Cile 1
HU - Ungheria 1
KR - Corea 1
RU - Federazione Russa 1
TR - Turchia 1
Totale 2.209
Città #
Rome 188
Fairfield 183
Singapore 164
Ashburn 133
Chandler 116
Woodbridge 76
Houston 65
Cambridge 63
Wilmington 61
Seattle 51
Princeton 41
Lomé 37
Sofia 28
Ann Arbor 27
San Paolo di Civitate 27
Vienna 27
Lawrence 17
Millbury 17
Boston 16
Plano 15
Beijing 10
Dearborn 10
San Diego 10
Teramo 10
Toronto 10
Andover 9
Dublin 8
Milan 8
Anguillara 7
Helsinki 7
Lavello 7
Legnano 7
Melbourne 7
Nanjing 6
Norwalk 6
Dobbs Ferry 5
Falls Church 5
Fiano Romano 4
Modena 4
Vedelago 4
Conegliano 3
Des Moines 3
Hoogstraten 3
Hyderabad 3
Laurel 3
Maddaloni 3
Montreal 3
Naples 3
Padova 3
Pomezia 3
Raleigh 3
Shenzhen 3
Tarragona 3
Verona 3
Woolwich 3
Amsterdam 2
Assisi 2
Baghdad 2
Barcelona 2
Bethesda 2
Blacklick 2
Brussels 2
Bühl 2
Cagliari 2
Cava de' Tirreni 2
Centrale 2
Chieti 2
Delhi 2
Fondi 2
Formia 2
Guatemala City 2
Ispra 2
Kuala Lumpur 2
Kunming 2
Lancaster 2
Las Vegas 2
Latina 2
Lausanne 2
Limena 2
London 2
Male 2
Monte Compatri 2
Motta Visconti 2
Neuenkirchen 2
New York 2
Okayama 2
Orte 2
Ottawa 2
Palermo 2
Perugia 2
Pessac 2
Phoenix 2
Pune 2
Rieti 2
Saint-Fons 2
Salerno 2
Solofra 2
Surat 2
Tivoli 2
Washington 2
Totale 1.631
Nome #
Next-Generation Probiotics for Inflammatory Bowel Disease 186
inPentasomes: an innovative nose-to-brain pentamidine delivery blunts MPTP parkinsonism in mice 105
Palmitoylethanolamide modulates inflammation-associated vascular endothelial growth factor (VEGF) signaling via the Akt/mTOR pathway in a selective peroxisome proliferator-activated receptor alpha (PPAR-α)-dependent manner. 92
Lathyrus sativus diamine oxidase counteracts histamine-induced cell proliferation, migration and pro-angiogenic mediators release in human colon adenocarcinoma cell line caco-2 91
Lathyrus sativus diamine oxidase reduces clostridium difficile toxin a-induced toxicity in caco-2 cells by rescuing rhoa-gtpase and inhibiting pp38-mapKknf-κb/hif-1α activation 82
Rifaximin, a non-absorbable antibiotic, inhibits the release of pro-angiogenic mediators in colon cancer cells through a pregnane X receptor-dependent pathway 80
Rifaximin improves clostridium difficile toxin A-induced toxicity in caco-2 cells by the PXR-dependent TLR4/MyD88/NF-κB pathway 80
HIV-1 Tat-induced diarrhea is improved by the PPAR alpha agonist, palmitoylethanolamide, by suppressing the activation of enteric glia 77
HIV-1 Tat-induced diarrhea evokes an enteric glia-dependent neuroinflammatory response in the central nervous system 74
Ultramicronized Palmitoylethanolamide Inhibits NLRP3 Inflammasome Expression and Pro-Inflammatory Response Activated by SARS-CoV-2 Spike Protein in Cultured Murine Alveolar Macrophages 72
Cannabidiol restores intestinal barrier dysfunction and inhibits the apoptotic process induced by Clostridium difficile toxin A in Caco-2 cells 71
Palmitoylethanolamide Exerts Antiproliferative Effect and Downregulates VEGF Signaling in Caco-2 Human Colon Carcinoma Cell Line Through a Selective PPAR-α-Dependent Inhibition of Akt/mTOR Pathway 71
Endocannabinoid-related compounds in gastrointestinal diseases 69
Engineered Lactobacillus paracasei Producing Palmitoylethanolamide (PEA) Prevents Colitis in Mice 68
Play in advance against neurodegeneration: exploring enteric glial cells in gut-brain axis during neurodegenerative diseases 68
A palmitoylethanolamide producing lactobacillus paracasei improves clostridium difficile toxin a-induced colitis 68
Pentamidine niosomes thwart S100B effects in human colon carcinoma biopsies favouring wtp53 rescue 65
Cannabidiol inhibits SARS-Cov-2 spike (S) protein-induced cytotoxicity and inflammation through a PPARγ-dependent TLR4/NLRP3/Caspase-1 signaling suppression in Caco-2 cell line 57
Phytotherapics in COVID19: why palmitoylethanolamide? 56
Role of Enteric Glia as Bridging Element between Gut Inflammation and Visceral Pain Consolidation during Acute Colitis in Rats 50
The potential of cannabidiol in the COVID-19 pandemic. 47
Can the enteric nervous system be an alternative entrance door in SARS-CoV2 neuroinvasion? 46
Impaired duodenal palmitoylethanolamide release underlies acid-induced mast cell activation in functional dyspepsia 46
High-fat diet impairs duodenal barrier function and elicits glia-dependent changes along the gut-brain axis that are required for anxiogenic and depressive-like behaviors 45
N-Palmitoyl-D-Glucosamine Inhibits TLR-4/NLRP3 and Improves DNBS-Induced Colon Inflammation through a PPAR-α-Dependent Mechanism 43
“Progetti per avvio alla ricerca” - Type 1 for year 2018 38
Young Researcher Award 2019 - Dipartimento di Fisiologia e Farmacologia "V. Erspamer", Università Sapienza di Roma 37
S100B protein stimulates proliferation and angiogenic mediators release through RAGE/pAkt/mTOR pathway in human colon adenocarcinoma Caco-2 Cells 37
Nutraceuticals and Diet Supplements in Crohn’s Disease: A General Overview of the Most Promising Approaches in the Clinic 37
Oral Adelmidrol Administration Up-Regulates Palmitoylethanolamide Production in Mice Colon and Duodenum through a PPAR-γ Independent Action 33
New blood-brain-barrier permeable compounds as Naegleria Fowleri CYP51 inhibitors. 29
Circuit-specific enteric glia regulate intestinal motor neurocircuits 27
Oral Immunization with Escherichia coli Nissle 1917 Expressing SARS-CoV-2 Spike Protein Induces Mucosal and Systemic Antibody Responses in Mice 26
HIV-1 Tat-induced diarrhea drives a glial inflammatory reaction to the central nervous system associated with a significant cognitive decline. 26
Sapienza starting grant research proposal 2019 26
PHARMACOGNOSY, PHYTOTHERAPY AND ENTERIC SYSTEM PHARMACOLOGY: INNOVATIVE APPROACHES FOR GREEN PHARMACOLOGICAL STRATEGIES 24
Regional heterogeneity of cholecystokinin sensing by enteric glia. 24
S100B Affects Gut Microbiota Biodiversity 22
Enteric glial biology, intercellular signaling, and roles in gastrointestinal disease 22
Mini-review: Interaction between intestinal microbes and enteric glia in health and disease 19
SIF fellowship for short period abroad 19
null 17
LPAR1 regulates enteric nervous system function through glial signaling and contributes to chronic intestinal pseudo-obstruction 17
Miconazole-like Scaffold is a Promising Lead for Naegleria fowleri-Specific CYP51 Inhibitors 16
Leaky gut, dysbiosis, and enteric glia activation: the trilogy behind the intestinal origin of Parkinson's disease 16
BQ788 Reveals Glial ETBR Modulation of Neuronal Cholinergic and Nitrergic Pathways to Inhibit Intestinal Motility: ETBR Signaling is Linked to POI 11
Intranasal delivery of PEA-producing Lactobacillus paracasei F19 alleviates SARSCoV- 2 spike protein-induced lung injury in mice 10
Functional Intraregional and Interregional Heterogeneity between Myenteric Glial Cells of the Colon and Duodenum in Mice 10
null 6
Intranasal administration of Escherichia coli Nissle expressing the spike protein of SARS-CoV-2 induces long-term immunization and prevents spike protein-mediated lung injury in mice 6
Sleeve Gastrectomy-Induced Body Mass Index Reduction Increases the Intensity of Taste Perception’s and Reduces Bitter-Induced Pleasantness in Severe Obesity 6
Intrarectal Administration of Adelmidrol plus Hyaluronic Acid Gel Ameliorates Experimental Colitis in Mice and Inhibits Pro-Inflammatory Response in Ex Vivo Cultured Biopsies Derived from Ulcerative Colitis-Affected Patients 4
Totale 2.374
Categoria #
all - tutte 6.342
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.342


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019107 0 0 0 0 0 0 0 0 0 0 47 60
2019/2020335 41 7 2 13 27 41 43 33 28 23 12 65
2020/2021209 16 18 24 6 4 37 6 14 12 28 31 13
2021/2022559 13 15 39 34 64 57 14 44 37 45 127 70
2022/2023525 85 86 14 52 55 53 18 44 49 15 38 16
2023/2024573 27 39 19 42 193 72 22 42 12 78 27 0
Totale 2.374